LifeMD, Inc. (LFMDP)’in fiyatı nedir?

LifeMD, Inc. (LFMDP)’in fiyatı $23.31’dir

LifeMD, Inc. (LFMDP)’in piyasa değeri nedir?

LifeMD, Inc. (LFMDP)’in piyasa değeri $1.05B’dir.

LifeMD, Inc. (LFMDP) Tedavüldeki Hisseler

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Yıl	Tedavüldeki Hisse Sayısı	Değiştir
2026 (TTM)	46.77M	13.54%
2024	41.20M	21.50%
2023	33.91M	9.45%
2022	30.98M	14.69%
2021	27.01M	89.20%
2020	14.28M	44.23%
2019	9.90M	12.00%
2018	8.84M	0.48%
2017	8.80M	24.78%
2016	7.05M	14.40%
2015	6.16M	1.44%
2014	6.07M	3.39%
2013	5.88M	6.73%
2012	5.50M	-26.77%
2011	7.52M	0.00%

Yıl

Tedavüldeki Hisse Sayısı

Değiştir

2026 (TTM)

46.77M

13.54%

2024

41.20M

21.50%

2023

33.91M

9.45%

2022

30.98M

14.69%

2021

27.01M

89.20%

2020

14.28M

44.23%

2019

9.90M

12.00%

2018

8.84M

0.48%

2017

8.80M

24.78%

2016

7.05M

14.40%

2015

6.16M

1.44%

2014

6.07M

3.39%

2013

5.88M

6.73%

2012

5.50M

-26.77%

2011

7.52M

0.00%

Şirket	Tedavüldeki Hisse Sayısı	Fark	Ülke
Alibaba Health Information Technology Limited 0241.HK	16.12B	34,366.45%	HK
Raia Drogasil S.A. RADL3.SA	1.75B	3,635.57%	BR
MatsukiyoCocokara & Co. 3088.T	397.93M	750.75%	JP
Yifeng Pharmacy Chain Co., Ltd. 603939.SS	1.21B	2,492.09%	CN
Sugi Holdings Co.,Ltd. 7649.T	180.97M	286.91%	JP

Şirket

Tedavüldeki Hisse Sayısı

Fark

Ülke